Shares in 4D Medical have soared up to 33%, after the US FDA approved the company’s CT:VQ lung imaging test for ventilation perfusion. The news sent 4D shares soaring up to 40%. 4D Medical describes ...
• The global computed tomography (CT) devices market was valued at USD 8.4 billion in 2024 and is set to grow at a CAGR of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback